| Financial Year |
March 31 2023 |
| Monetary Funds |
67,960,225,605.98 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
934,538,656.25 |
| Accounts Receivable |
9,015,428,991.23 |
| Advances to Suppliers |
18,249,789,277.29 |
| Other Receivables |
967,558,280.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
5,819,486.88 |
| Inventories |
29,004,585,106.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
333,607,825.75 |
| Other Current Assets |
700,490,828.31 |
| Total Current Assets |
132,378,110,424.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
597,417,055.74 |
| Long-term Equity Investment |
9,630,571,756.34 |
| Investment Properties |
35,063,956.77 |
| Fixed Assetes |
31,688,208,281.86 |
| Under-construction Projects |
2,715,076,211.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,467,154,661.40 |
| R&D expenses |
114,311,366.43 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
109,070,093.56 |
| Deferred Income Tax Assets |
1,250,927,257.09 |
| Other Non-Current Assets |
178,223,503.44 |
| Sub-Total of Non-Current Assets |
54,710,204,254.70 |
| Total Assets |
187,088,314,678.95 |
| Short-Term Loans |
2,875,004,994.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,777,388,037.80 |
| Accounts Payable |
22,948,822,610.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
272,895,474.28 |
| Taxes Payable |
157,925,773.44 |
| Interest Payable |
-- |
| Dividend Payable |
301,627.29 |
| Other payables |
1,919,703,667.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,100,807,554.91 |
| Other Current Liabilities |
289,263,267.55 |
| Sub-Total of Current Liabilities |
78,028,550,580.42 |
| Long-term Loans |
16,635,160,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,832,580,678.51 |
| Special Payable |
-- |
| Estimatied Liabilities |
594,014,638.25 |
| Deferred Income Tax Liabilities |
1,274,290,067.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,654,100,204.05 |
| Total Liabilities |
102,682,650,784.47 |
| Paid-In Capital(Or Share Stock) |
22,802,035,324.00 |
| Capital Surplus |
44,732,984,621.28 |
| Surplus Reserve |
2,187,000,441.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
12,235,019,902.52 |
| Minority Stockholder's Interest |
592,829,439.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
83,812,834,455.08 |
| Owner's Equity（Stockholder's Equity） |
84,405,663,894.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
187,088,314,678.95 |
